DENTSPLY SIRONA (NASDAQ:XRAY) Downgraded by StockNews.com

StockNews.com downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a buy rating to a hold rating in a research note published on Friday.

A number of other analysts have also weighed in on the stock. Needham & Company LLC dropped their target price on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a report on Friday. Barrington Research reduced their target price on DENTSPLY SIRONA from $41.00 to $38.00 and set an outperform rating on the stock in a research note on Friday. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating on the stock in a research report on Friday. Piper Sandler reaffirmed a neutral rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday. Finally, SVB Leerink began coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an outperform rating and a $42.00 price target for the company. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of Moderate Buy and an average price target of $35.22.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $28.25 on Friday. The company’s fifty day moving average is $32.02 and its 200 day moving average is $32.69. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 52 week low of $26.27 and a 52 week high of $41.65. The stock has a market cap of $5.87 billion, a PE ratio of -64.20, a PEG ratio of 1.24 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same period last year, the company earned $0.39 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 2.6% compared to the same quarter last year. Research analysts anticipate that DENTSPLY SIRONA will post 2.04 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a $0.16 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.27%. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently modified their holdings of the company. Exchange Traded Concepts LLC boosted its stake in shares of DENTSPLY SIRONA by 41.2% during the 3rd quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after acquiring an additional 439 shares during the last quarter. Asset Management One Co. Ltd. grew its holdings in DENTSPLY SIRONA by 5.0% during the third quarter. Asset Management One Co. Ltd. now owns 89,835 shares of the medical instruments supplier’s stock valued at $3,069,000 after purchasing an additional 4,294 shares during the period. Xponance Inc. raised its stake in shares of DENTSPLY SIRONA by 12.4% in the third quarter. Xponance Inc. now owns 37,292 shares of the medical instruments supplier’s stock worth $1,274,000 after buying an additional 4,114 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of DENTSPLY SIRONA by 132.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 83,817 shares of the medical instruments supplier’s stock valued at $2,863,000 after buying an additional 47,748 shares in the last quarter. Finally, Strs Ohio grew its stake in shares of DENTSPLY SIRONA by 14.6% during the 3rd quarter. Strs Ohio now owns 47,167 shares of the medical instruments supplier’s stock valued at $1,611,000 after acquiring an additional 6,021 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.